JPMorgan Downgrades Syneos (SYNH) to Underweight, 'Little Visibility into 2023 Clinical Improvement'
Tweet Send to a Friend
(Updated - February 13, 2023 3:30 AM EST)
JPMorgan analyst Casey Woodring downgraded Syneos (NASDAQ: SYNH) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Casey Woodring downgraded Syneos (NASDAQ: SYNH) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
